Weekly CEO Buys Highlight

Details the CEO buys this past week from the following companies: American Assets Trust, Sohu.com, Inovalon Holdings, Tenneco and Amphastar Pharmaceuticals

Author's Avatar
May 21, 2018
Article's Main Image

According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

American Assets Trust CEO bought 113,202 shares

American Assets Trust Inc. (AAT, Financial) Chairman, CEO, President and 10% owner Ernest S. Rady bought 113,202 shares during the past week at an average price of $34.80.

American Assets Trust is a self-administered real estate investment trust based in the U.S. The company mainly invests in, operates and develops retail, office, residential and mixed-use properties in California, Oregon and Hawaii. The company has a market cap of $2.19 billion. Its shares traded at $34.08 with a price-earnings (P/E) ratio of 54.79 as of May 18.

Net loss for the first quarter of 2018 was $500,000 compared to net income of $7.4 million for the first quarter 2017.

Rady bought 47,562 shares on May 9 at a price of $34.9; 4,710 shares on May 11 at a price of $35.17; 64,125 shares on May 14 at a price of $35.04; and 44,367 shares on May 18 at a price of $34.41. The price of the stock has decreased by 0.96% since.

Sohu.com CEO bought 56,500 shares

Sohu.com Inc. (SOHU, Financial) CEO and 10% owner Charles Zhang bought 56,500 shares during the past week at an average price of $36.44.

Sohu.com is a Chinese online media, search and game service group. It provides comprehensive online products and services on PCs and mobile devices in the People's Republic of China. The company has a market cap of $1.40 billion. Its shares traded at $36.08 as of May 18.

Net loss for the first quarter of 2018 was $93 million compared to $69 million in the first quarter of 2017.

Zhang bought 128,940 shares on May 1 at a price of $30.89; 100,000 shares on May 9 at a price of $35.34; 20,000 shares on May 11 at a price of $36.03; 16,500 shares on May 15 at a price of $36.53; and 20,000 shares on May 17 at a price of $36.78. The price of the stock has decreased by 1.9% since.

10% Owner Group Ltd. Photon bought 128,940 shares on May 1 at a price of $30.89; 100,000 shares on May 9 at a price of $35.34; 20,000 shares on May 11 at a price of $36.03; 16,500 shares on May 15 at a price of $36.53; and 20,000 shares on May 17 at a price of $36.78. The price of the stock has decreased by 1.9% since.

Inovalon Holdings CEO bought 118,000 shares

Inovalon Holdings Inc. (INOV, Financial) CEO, Chairman of the Board and 10% owner Keith R. Dunleavy bought 118,000 shares on May 16 at a price of $9.91. The price of the stock has increased by 3.94% since.

Inovalon Holdings is a U.S.-based technology company. It delivers seamless, end-to-end platforms that bring the benefits of big data and large-scale analytics to the point of care. The company has a market cap of $1.57 billion. Its shares traded at $10.30 with a price-earnings (P/E) ratio of 43.28 as of May 18.

Net loss for the first quarter of 2018 was $16.8 million compared to net income of $3.6 million for the first quarter of 2017.

Tenneco CEO bought 21,500 shares

Tenneco Inc. (TEN, Financial) CEO Brian J. Kesseler bought 21,500 shares on May 11 at a price of $46.63. The price of the stock has increased by 1.82% since.

Tenneco produces clean air and ride performance products and systems for light vehicle, commercial truck, off-highway and other vehicle applications. It serves original equipment vehicle manufacturers and repair and replacement markets or aftermarket. The company has a market cap of $2.44 billion. Its shares traded at a price of $47.48 with a price-earnings (P/E) ratio of 12.14 as of May 18.

Net income for the first quarter of 2017 was $59 million.

Amphastar Pharmaceuticals CEO bought 40,000 shares

Amphastar Pharmaceuticals Inc. (AMPH, Financial) CEO, Chief Scientific Officer and 10% Owner Jack Y. Zhang bought 40,000 shares on May 16 at a price of $16.07. The price of the stock has increased by 3.48% since.

Amphastar Pharmaceuticals is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable and inhalation products. Its products are used in hospitals or urgent care clinical settings. The company has a market cap of $775.19 million. Its shares traded at $16.63 with a price-earnings (P/E) ratio of 184.78 as of May 18.

Net loss for the first quarter of 2018 was $7.25 million compared to $893,000 for the prior-year period.

For the complete list of stocks that bought by their companies' CEOs, go to: CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned in the article.